_PRIVATE_LIMITED.webp)
Meirs Pharma (India) Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 2.50 M
- Company Age 39 Year, 11 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 3.11 Cr
- Revenue Growth %
- Profit Growth 29.52%
- Ebitda 60.41%
- Net Worth -0.15%
- Total Assets -1.09%
About Meirs Pharma (India)
Meirs Pharma (India) Private Limited (MPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 March 1985 and has a history of 39 years and 11 months. Its registered office is in Karaikal, Pondicherry.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹3.11 Cr.
Bairavan Chettiar, Bhupendra Nirula, Ramaswamy Bairavan, and One other member serve as directors at the Company.
Company Details
- Location Karaikal, Pondicherry
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24305PY1985PTC000311
- Company No.
000311
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 1985
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
Healthcare
Who are the key members and board of directors at Meirs Pharma (India)?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bairavan Chettiar  | Director | 05-Sep-1990 | Current |
| Bhupendra Nirula | Director | 03-Apr-1985 | Current |
| Ramaswamy Bairavan | Director | 27-Mar-1985 | Current |
| Arunachalam Kannappan | Director | 27-Mar-1985 | Current |
Financial Performance of Meirs Pharma (India).
Meirs Pharma (India) Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 29.52% increase in profit. The company's net worth dipped by a decrease of 0.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meirs Pharma (India)?
In 2017, Meirs Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹31.10 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Pondicherry Indul . Promotion Dev. And Investment Corpn. Ltd : 0.90 Cr
- Pipdic Ltd. : 0.90 Cr
- Bank Of Madura Ltd. : 0.84 Cr
- Bank Of Madura : 0.47 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Dec 1993 | Bank Of Madura | ₹2.70 M | Open |
| 28 May 1992 | Bank Of Madura | ₹1.20 M | Open |
| 18 Mar 1992 | Bank Of Madura | ₹0.80 M | Open |
| 09 Nov 1991 | Bank Of Madura Ltd. | ₹6.30 M | Open |
| 12 Jul 1990 | Bank Of Madura Ltd. | ₹2.10 M | Open |
How Many Employees Work at Meirs Pharma (India)?
Meirs Pharma (India) has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meirs Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meirs Pharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
